Latest Industry News & Trends

Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.

Emerging News

11/14/2024
AIDiagnosticEmergingGlaucomaNewsletterOcular CancerRegulationRetinaTelehealth
Emerging Companies Pursuing Ophthalmic Indications, November 2024
Emerging Companies Pursuing Ophthalmic Indications, November 2024

Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.

10/15/2024
DiagnosticDry EyeEmergingLow VisionNewsletterRetina
Emerging Companies Pursuing Ophthalmic Indications, October 2024
Emerging Companies Pursuing Ophthalmic Indications, October 2024

Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.

9/19/2024
Dry EyeEmergingGene TherapyNewsletterRetinaSurgical
Emerging Companies Pursuing Ophthalmic Indications, September 2024
Emerging Companies Pursuing Ophthalmic Indications, September 2024

Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.

9/6/2024
BreakingEmergingGene TherapyRetina
Tern Therapeutics Launches with $15 Million Financing and Pipeline in CLN2 Batten Disease 
Tern Therapeutics Launches with $15 Million Financing and Pipeline in CLN2 Batten Disease

Tern Therapeutics announced its launch Aug. 27, along with closing of a $15 million financing. The company also reported that it had licensed gene therapy candidates RGX-381 and RGX-181 (now design...

8/21/2024
CornealDry EyeEmergingNewsletterRetina
Emerging Companies Pursuing Ophthalmic Indications, August 2024
Emerging Companies Pursuing Ophthalmic Indications, August 2024

Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.

7/23/2024
ChinaEmergingGene TherapyGlaucomaNewsletterRetina
Emerging Companies Pursuing Ophthalmic Indications, July 2024
Emerging Companies Pursuing Ophthalmic Indications, July 2024

Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.

7/19/2024
BreakingEmergingRegulationRetina
NexThera Files IND with US FDA for Trial of Wet AMD Eye Drop Candidate
NexThera Files IND with US FDA for Trial of Wet AMD Eye Drop Candidate

NexThera, of Busan, South Korea, announced July 16 that it had filed an investigational new drug (IND) application with the US FDA for a Phase I/IIa trial of NT-101, an eye drop candidate for wet a...

7/11/2024
BreakingChinaEmergingRetina
China’s DP Technology Will Advance Oral Lp-PLA2 Inhibitor for DR and DME
China’s DP Technology Will Advance Oral Lp-PLA2 Inhibitor for DR and DME

China’s DP Technology announced July 8 that it would advance DPT0415, a novel small molecule targeting lipoprotein‐associated phospholipase A2 (Lp-PLA2), as a potential oral treatment candidate for...

6/24/2024
DiagnosticEmergingMicroscopesNewsletterPharmaSurgicalTelehealth
Emerging Companies Pursuing Ophthalmic Indications, June 2024
Emerging Companies Pursuing Ophthalmic Indications, June 2024

Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.

5/22/2024
CornealDiagnosticDry EyeEmergingGene TherapyGlaucomaNewsletterOcular CancerRetinaSurgical
Emerging Companies Pursuing Ophthalmic Indications, May 2024
Emerging Companies Pursuing Ophthalmic Indications, May 2024

Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.

4/24/2024
CornealEmergingIndiaNewsletter
Emerging Companies Pursuing Ophthalmic Indications, April 2024
Emerging Companies Pursuing Ophthalmic Indications, April 2024

Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.

4/12/2024
BreakingEmergingEuropeFundingGlaucomaSurgical
LEP Raises Funding to Advance Glaucoma Implant Targeting Inflammation, Fibrosis
LEP Raises Funding to Advance Glaucoma Implant Targeting Inflammation, Fibrosis

Ireland-based LEP Biomedical reported April 4 that it had closed a pre-seed funding round of €100 thousand to advance its HyaGuard platform. HyaGuard is a biodegradable, subconjunctival insert desi...

3/21/2024
AllergyDiagnosticDry EyeEmergingGene TherapyGlaucomaNewsletterRetina
Emerging Companies Pursuing Ophthalmic Indications, March 2024
Emerging Companies Pursuing Ophthalmic Indications, March 2024

Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.

3/1/2024
BreakingEmergingGene TherapyRetina
France’s PulseSight Therapeutics Launches to Advance Non-viral Retinal Gene Therapies
France’s PulseSight Therapeutics Launches to Advance Non-viral Retinal Gene Therapies

France’s PulseSight Therapeutics, developing non-viral ophthalmic gene therapies, launched Feb. 28 with an undisclosed seed financing from Pureos Bioventures and ND Capital. A spokeswoman for Pulse...

2/22/2024
CornealEmergingGlaucomaNewsletterRetina
Emerging Companies Pursuing Ophthalmic Indications, February 2024
Emerging Companies Pursuing Ophthalmic Indications, February 2024

Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.

1/23/2024
CornealEmergingNewsletter
Emerging Companies Pursuing Ophthalmic Indications, January 2024
Emerging Companies Pursuing Ophthalmic Indications, January 2024

Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.

12/14/2023
BiosimilarsEmergingGene TherapyGlaucomaNewsletterRetina
Emerging Companies Pursuing Ophthalmic Indications, December 2023
Emerging Companies Pursuing Ophthalmic Indications, December 2023

Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.

12/8/2023
BiosimilarsBreakingEmergingIndiaRetina
India’s Enzene Biosciences Launches Ranibizumab Biosimilar for Wet AMD
India’s Enzene Biosciences Launches Ranibizumab Biosimilar for Wet AMD

Enzene Biosciences announced in November that it had launched a ranibizumab biosimilar for the treatment of wet age-related macular degeneration (AMD). The product references Lucentis, which is sol...

11/21/2023
CornealDiagnosticEmergingGene TherapyGlaucomaNewsletterRetinaSurgical
Emerging Companies Pursuing Ophthalmic Indications, November 2023
Emerging Companies Pursuing Ophthalmic Indications, November 2023

Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.

10/24/2023
ChinaDiagnosticDry EyeEmergingGene TherapyGlaucomaNewsletterRetina
Emerging Companies Pursuing Ophthalmic Indications, October 2023
Emerging Companies Pursuing Ophthalmic Indications, October 2023

Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.

9/21/2023
EmergingNewsletterRetina
Emerging Companies Pursuing Ophthalmic Indications, September 2023
Emerging Companies Pursuing Ophthalmic Indications, September 2023

Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.

8/22/2023
CornealEmergingMyopiaNewsletterRetina
Emerging Companies Pursuing Ophthalmic Indications, August 2023
Emerging Companies Pursuing Ophthalmic Indications, August 2023

Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.

8/4/2023
BreakingCornealDealsEmerging
Verséa Ophthalmics Signs Deal to Distribute Celularity’s Amniotic Allografts in the US
Verséa Ophthalmics Signs Deal to Distribute Celularity’s Amniotic Allografts in the US

Celularity and Verséa Ophthalmics announced an exclusive US commercial agreement on July 27. Verséa will distribute Celularity’s Biovance and Biovance 3L for ocular surface disease and ocular surgi...

Want to Read the Full Article?

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more